AXIS-SHIELD INNOVATION FOR LIFE
LIVE

Serial Number

79085615

Owner

Axis-Shield plc

Attorney

Michele H. Bowman

Filing Date

Jun 14, 2010

Add to watchlist:

No watchlists yet
View on USPTO

AXIS-SHIELD INNOVATION FOR LIFE Trademark

Serial Number: 79085615 • Registration: 4085678

AXIS-SHIELD INNOVATION FOR LIFE is a trademark filed by Axis-Shield plc on June 14, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Axis-Shield plc

Luna Place
Dundee DD2 1XA , GB

Entity Type: 11

Axis-Shield Diagnostics Limited (2 trademarks)

Luna Place,
Dundee DD2 1XA , GB

Entity Type: 99

Axis-Shield Limited

Luna Place,

Entity Type: 11

Trademark Details

Filing Date

June 14, 2010

Registration Date

January 17, 2012

Published for Opposition

November 1, 2011

Goods & Services

Chemical reagents and preparations for medical purposes, for treating or diagnosing critical illnesses in the nature of diabetes, diabetic renal, cardiovascular and neurodegenerative diseases, rheumatoid arthritis, deep vein thrombosis, pulmonary embolisms, vitamin deficiencies, bacterial or viral infections, including sepsis, inflammation, and anticoagulation monitoring; chemical reagents and preparations for medical use, for diagnostic purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical use, for sale in kit form, consisting of two or more of conjugates, membrane tubes, washing solutions, reagents, reconstitution reagents, precipitation agents, stabilised human whole blood, stabilised porcine whole blood, citrate buffers, substrates, stop solutions, wash buffers, diluents, human plasma, human serum, control solutions, dilution liquids and dilution buffers; diagnostic preparations and reagents for medical purposes, for in-vitro use; diagnostic kits for medical use, consisting primarily of reagents; chemical preparations for laboratory use, for medical purposes, for use in treating or diagnosing critical illnesses in the nature of diabetes, diabetic renal, cardiovascular and neurodegenerative diseases, rheumatoid arthritis, deep vein thrombosis, pulmonary embolisms, vitamin deficiencies, bacterial or viral infections, including sepsis, inflammation, and anticoagulation monitoring; medical diagnostic reagents for biological and chemical assays

Diagnostic preparations for scientific use, for the detection of bacteria and antibodies to said bacteria

Medical diagnostic apparatus and instruments, all for sale in kit form, namely, multiassay analysers, reagent cartridges, sampling devices, blood sampling devices, assay analysers, blood analysers, serum analysers, plasma analysers, urine sampling devices, urine analysers, membrane tubes, capillaries, microtitre plates, microtitre strips and pipettes; apparatus for use in the diagnosis of ailments, namely, multiassay analysers, assay analysers, blood analysers, serum analysers, plasma analysers, urine sampling devices, urine analysers, reagent cartridges, sampling devices, blood sampling devices, urine sampling devices, membrane tubes, capillaries, microtitre plates, microtitre strips and pipettes; and structural or replacement parts and fittings for all the aforesaid goods

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 8, 2023 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 29, 2022 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 29, 2022 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 22, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 18, 2022 ES75
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jan 17, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Jul 2, 2020 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Jun 22, 2018 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 21, 2017 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 21, 2017 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 20, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Nov 27, 2017 ES75
CHANGE OF OWNER RECEIVED FROM IB
Sep 28, 2017 CHLD
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 7, 2017 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 17, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 4, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 18, 2012 FICS
FINAL DISPOSITION PROCESSED
Apr 18, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 17, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Dec 30, 2011 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 12, 2011 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 24, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2011 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 2, 2011 GNFN
FINAL REFUSAL E-MAILED
May 2, 2011 GNFR
FINAL REFUSAL WRITTEN
May 2, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2011 CRFA
ASSIGNED TO LIE
Mar 31, 2011 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 30, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2011 REAP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 30, 2011 TROA
REFUSAL PROCESSED BY IB
Oct 16, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 30, 2010 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 30, 2010 RFCR
NON-FINAL ACTION WRITTEN
Sep 29, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2010 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 1, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2010 REPR